Table 1.
Clinical characteristics of the study patients with obstructive sleep apnea (n = 116)
| Age, y | 57.9 ± 13.7 |
| Men/women, No. (%) | 99/17 (85.3/14.7) |
| BMI, kg/m2 | 29.2 ± 5.5 |
| Hypertension, % | 70.7 |
| Hyperlipidemia, % | 25.9 |
| Diabetes mellitus, % | 16.4 |
| History of angina, % | 6.9 |
| History of myocardial infarction, % | 5.2 |
| History of stroke, % | 4.3 |
| Antihypertensive drugs, % | 66.4 |
| Calcium channel blockers, % | 43.1 |
| ACEIs/ARBs, % | 56.0 |
| Diuretics, % | 30.2 |
| Other, % | 17.2 |
| PSG‐derived parameters | |
| Apnea‐hypopnea index, per h | 39.6 ± 17.5 |
| Apnea index, per h | 19.0 ± 16.1 |
| Arousal index, per h | 35.7 ± 16.5 |
| Lowest SpO2, % | 74.8 ± 8.3 |
| SpO2 < 90%, % | 16.8 ± 17.2 |
ACEIs, angiotensin‐converting enzyme inhibitors; ARBs, angiotensin receptor blockers; BMI, body mass index; SpO2, oxygen saturation.
Data are expressed as mean ± standard deviation or percentage. Polysomnography (PSG)‐derived parameters are the average value of each parameter on two consecutive days.